Ligand Pharmaceuticals, Inc.

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
02/09/18 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 5
02/07/18 UPLOAD SEC-generated letter 1
01/29/18 8-K Current report filing 3
01/26/18 4 Statement of changes in beneficial ownership of securities 2
01/22/18 4 Statement of changes in beneficial ownership of securities 2
01/19/18 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 6
01/17/18 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 6
01/11/18 4 Statement of changes in beneficial ownership of securities 2
12/29/17 4 Statement of changes in beneficial ownership of securities 2
12/29/17 4 Statement of changes in beneficial ownership of securities 2
RSS